Commissioner Succession Plan? Abernethy As Gottlieb’s Number Two Offers One Option
Gottlieb’s choice of Amy Abernethy as US FDA principal deputy could set her up to succeed him, should the need arise. CDER’s Cavazzoni will fill the post on temporary basis, elevating her profile within agency.
You may also be interested in...
As is tradition, political appointments offer resignations when a new administration takes office. The incoming president can ask them to stay but often they are let go. Commissioner Hahn is expected to be among the many Trump administration agency heads who will depart.
Plan specifying the acting head of FDA until new commissioner is confirmed references senior positions that no longer exist.
Norman Sharpless, director of the National Cancer Institute, will become acting FDA commissioner when Scott Gottlieb departs.